Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Biora Therapeutics, Inc. (BIORQ) vs Matinas Biopharma Holdings, Inc. (MTNB)

Biora Therapeutics, Inc. and Matinas Biopharma Holdings, Inc. are both Biotechnology companies. Biora Therapeutics, Inc. and Matinas Biopharma Holdings, Inc. are of similar size ($2.5M and $2.4M). Matinas Biopharma Holdings, Inc. grew revenue faster over the last twelve months: 2,139.4% against 347.0%. Matinas Biopharma Holdings, Inc. has the higher net margin (0.00% vs −3,527.9%) and the lower return on invested capital (−419.3% vs 0.00%). Across the 16 metrics below, Matinas Biopharma Holdings, Inc. leads on 9 and Biora Therapeutics, Inc. on 7.

Valuation

Metric BIORQ MTNB Biotechnology median
P/E n/m n/m 7.88
P/S n/m 0.24 11.47
P/B n/m 0.57 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 67.44 0.05 10.73
Earnings yield 0.00% (731.25%) (28.84%)
Free cash flow yield 0.00% (595.22%) (23.03%)

Profitability

Metric BIORQ MTNB Biotechnology median
Gross margin 85.79% 0.00% 65.16%
Operating margin (6,809.06%) 0.00% 0.00%
Net margin (3,527.85%) 0.00% 0.00%
Free cash flow margin (5,165.88%) 0.00% 0.00%
Return on equity 27.98% (154.28%) (57.72%)
Return on assets (128.19%) (98.53%) (49.22%)
Return on invested capital 0.00% (419.27%) 0.00%

Growth

Metric BIORQ MTNB Biotechnology median
Revenue growth (TTM) 347.00% 2,139.41% 5.64%
EPS growth (last fiscal year) (57.40%) 59.84% —
Revenue growth, 5-year CAGR (87.44%) 55.69% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIORQ MTNB Biotechnology median
Debt to equity (0.18) 0.00 0.00
Current ratio 0.05 0.85 4.73
Net debt to EBITDA (0.47) 0.62 0.96

Dividend

Metric BIORQ MTNB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BIORQ MTNB Biotechnology median
Market cap 2.49m 2.41m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack